Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
GROWTH, short for Guideline & Research Organizations Worldwide for Transparency & Harmonization, is an evidence-based medicine collaboration initiative created by Doctor Evidence. Based on the information on the page, its goal is to promote the dissemination of evidence-based knowledge and methods through global collaboration and data sharing, supporting clinical research, guideline recommendations, and health technology assessment. From an education/course perspective, it is closer to a professional knowledge resource and institutional collaboration platform than a conventional recorded course or bootcamp.
The page lists three types of initiatives: DOC Search, GROWTH Evidence, and GROWTH Research. These are aimed at medical professional societies, clinical researchers, healthcare providers, evidence-based practice centers, guideline panels, academic research centers, and hospital systems. The main publicly available content is GROWTH Commentaries: monthly open-access expert essays covering topics such as evidence-based medicine, real-world evidence, digital health, clinical guideline dissemination, and public policy. The text does not show live sessions, recorded videos, 1-on-1 mentoring, schedules, or homework mechanisms, so it should not be regarded as a standard course product.
The faculty and author backgrounds appear strong, with experts such as Eric Topol and Heiner C. Bucher from fields including medicine, clinical epidemiology, and digital health mentioned on the page. Doctor Evidence is also described as a professional resource for systematic reviews and evidence-based medicine products, with collaboration examples such as involvement in ACC/AHA/HRS guideline evidence reviews and the ASH abstract platform. Certification/certificates, course pricing, and payment methods do not appear in the crawled text, while GROWTH Commentaries are explicitly described as open-access essays.
Its strengths are its professional depth and focus on evidence-based medicine, systematic reviews, real-world evidence, and guideline development, making it suitable for institutional and research-oriented users. The public commentaries can also serve as a useful resource for understanding methodological and policy trends in the field. The downsides are that it is not structured like a course and lacks a learning path, assessments, certificates, and pricing information. The content is aimed at medical professionals, creating a relatively high barrier for general learners, and no Chinese-language support was observed.
It is better suited to medical professional societies, clinical researchers, hospital research departments, evidence-based practice centers, and guideline development teams. It is less suitable for individual learners looking for an introductory course or career certificate. The text does not specify access or payment availability from mainland China, so actual access testing is recommended. Alternatives to consider include Cochrane, BMJ Best Practice, UpToDate, as well as evidence-based medicine and clinical research courses on Coursera/edX.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on growthevidence.com official site.
growthevidence.com is an United States Education provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach growthevidence.com directly.